METHOD FOR THE TREATMENT OF MALARIA BY THE USE OF PRIMAQUINE DERIVATIVE N1-(3-ETHYLIDINOTETRAHYDROFURAN-2-ONE) -N 4-(6-METHOXY-8-QUINOLINYL)-1,4-PENTANEDIAMINE AS GAMETOCYTOCIDAL AGENT
申请人:——
公开号:US20030199697A1
公开(公告)日:2003-10-23
The present invention a novel use of primaquine derivative N
1
-(3-ethylidinotetrahydrofuran-2-one)-N
4
-(6-methoxy-8-quinolinyl)-1,4-pentanediamine in the treatment and contolling the spread of malaria. In particular, the present invention discloses a method of treatment of malaria by the use of primaquine derivative N
1
-(3-ethylidinotetrahydrofuran-2-one)-N
4
-(6-methoxy-8-quinolinyl)-1,4-pentanediamine as a gametocytocidal agent.
本发明涉及一种新的利用盐酸伯氨喹衍生物N1-(3-乙烯基四氢呋喃-2-酮)-N4-(6-甲氧基-8-喹啉基)-1,4-戊二胺治疗和控制疟疾传播的方法。特别是,本发明揭示了一种利用盐酸伯氨喹衍生物N1-(3-乙烯基四氢呋喃-2-酮)-N4-(6-甲氧基-8-喹啉基)-1,4-戊二胺作为配子体杀虫剂治疗疟疾的方法。